Community pharmacists’ role in benzodiazepine supply in Ireland: a questionnaire of pharmacists’ views and experiences

Cadogan, Cathal; Ryder, Sheila A.

doi:10.1111/ijpp.12182

Cited by 8 publications

(2 citation statements)

References 41 publications

(57 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Once patients have a plan, in an interdisciplinary model, pharmacists should be apprised of the plan (which could be written out as a prescription) for further facilitating patient adherence to the plan with supportive advice. Indeed, data suggest that community pharmacists do frequently encounter chronic benzodiazepine use in practice, but fewer than half converse with the patient about ongoing use . On the other hand, a recent study in Australia highlighted that pharmacists could be successfully trained to deliver behavioural interventions with positive sleep health outcomes in patients with insomnia, suggesting the benefit of developing pharmacist roles in this area.…”

Section: Discussionmentioning

confidence: 99%

“…On the other hand, a recent study in Australia highlighted that pharmacists could be successfully trained to deliver behavioural interventions with positive sleep health outcomes in patients with insomnia, suggesting the benefit of developing pharmacist roles in this area. Despite the potential to play key roles in benzodiazepine deprescribing, pharmacists, especially community pharmacists, are currently underutilised …”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Benzodiazepine usage and patient preference for alternative therapies: A descriptive study

Sake

Wong

Bartlett

et al. 2019

Health Science Reports

View full text Add to dashboard Cite

Background and aims The prevalence of chronic benzodiazepine use in primary care settings remains high despite clear evidence of adverse health outcomes resulting from long‐term use and the availability of effective alternative behavioural therapies. Eliciting factors influencing past or current usage experience of benzodiazepine users and their future behavioural intention regarding discontinuation or alternative behavioural therapy adoption could be useful in developing informed strategies facilitating successful benzodiazepine withdrawal in long‐term users. The aim of this study was to identify patient factors influencing their current long‐term benzodiazepine use, past withdrawal attempt, and future intention to trial safer alternative behavioural therapies. Additionally, the study also aimed to explore patients' preference for information sources on behavioural therapies. Methods Point of purchase surveys were conducted with patients obtaining benzodiazepines from selected pharmacies across New South Wales (NSW), Australia. Survey items included the Beliefs about Medicines Questionnaire (BMQ‐specific), questions about patient's sociodemographic characteristics, as well as their views about long‐term benzodiazepine use and behavioural therapies. Results Seventy‐five patients were recruited from 12 pharmacies across New South Wales (NSW). The surveys were conducted from November 2016 to July 2017. The mean (±SD) age of the participants was 54.3 (±16.7) with a range of 23 to 86 years, and 67% of the participants had been using the benzodiazepine for at least 1 year. Lower‐education levels, stronger beliefs about the necessity of use, and lower concerns about ongoing benzodiazepine use were significantly associated with prolonged use. Sixty‐four percent of the participants were not interested in behavioural therapies, and there was a significant relationship between the participants' future preference for behavioural therapies and their concerns about the potential adverse effects of benzodiazepines. A majority of the participants rated general practitioners (GPs) as their first choice and pharmacists as the second choice for discussing behavioural therapies. Conclusions Specific individual sociodemographic characteristics of benzodiazepine users and their medication‐related beliefs influence their current benzodiazepine usage and future intention to trial behavioural therapies as an alternative to their benzodiazepines. Based on the reported preferences of benzodiazepine users in this study, developing and evaluating GP‐pharmacist collaborative services to improve the uptake of behavioural therapies as an alternative to benzodiazepines can be recommended.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Benzodiazepine usage and patient preference for alternative therapies: A descriptive study

Sake

Wong

Bartlett

et al. 2019

Health Science Reports

View full text Add to dashboard Cite

show abstract

Development of a pharmacy practice intervention: lessons from the literature

2015

View full text Add to dashboard Cite

The development of health interventions is receiving increasing attention within the scientific literature. In the past, interventions were often based on the ISLAGIATT principle: that is, 'It seemed like a good idea at the time'. However, such interventions were frequently ineffective because they were either delivered in part or not at all, demonstrating a lack of fidelity, or because little attention had been paid to their development, content, and mode of delivery. This commentary seeks to highlight the latest methodological advances in the field of intervention development, drawing on health psychology literature, together with guidance from key organisations and research consortia which are setting standards for development and reporting. Those working within pharmacy practice research can learn from the more systematic approach being advocated, and apply these methods to help generate evidence to support new services and professional roles.

show abstract

What is polypharmacy? A systematic review of definitions

et al. 2017

View full text Add to dashboard Cite

BackgroundMultimorbidity and the associated use of multiple medicines (polypharmacy), is common in the older population. Despite this, there is no consensus definition for polypharmacy. A systematic review was conducted to identify and summarise polypharmacy definitions in existing literature.MethodsThe reporting of this systematic review conforms to the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) checklist. MEDLINE (Ovid), EMBASE and Cochrane were systematically searched, as well as grey literature, to identify articles which defined the term polypharmacy (without any limits on the types of definitions) and were in English, published between 1st January 2000 and 30th May 2016. Definitions were categorised as i. numerical only (using the number of medications to define polypharmacy), ii. numerical with an associated duration of therapy or healthcare setting (such as during hospital stay) or iii. Descriptive (using a brief description to define polypharmacy).ResultsA total of 1156 articles were identified and 110 articles met the inclusion criteria. Articles not only defined polypharmacy but associated terms such as minor and major polypharmacy. As a result, a total of 138 definitions of polypharmacy and associated terms were obtained. There were 111 numerical only definitions (80.4% of all definitions), 15 numerical definitions which incorporated a duration of therapy or healthcare setting (10.9%) and 12 descriptive definitions (8.7%). The most commonly reported definition of polypharmacy was the numerical definition of five or more medications daily (n = 51, 46.4% of articles), with definitions ranging from two or more to 11 or more medicines. Only 6.4% of articles classified the distinction between appropriate and inappropriate polypharmacy, using descriptive definitions to make this distinction.ConclusionsPolypharmacy definitions were variable. Numerical definitions of polypharmacy did not account for specific comorbidities present and make it difficult to assess safety and appropriateness of therapy in the clinical setting.

show abstract

Community pharmacists’ role in benzodiazepine supply in Ireland: a questionnaire of pharmacists’ views and experiences

Cited by 8 publications

References 41 publications

Benzodiazepine usage and patient preference for alternative therapies: A descriptive study

Benzodiazepine usage and patient preference for alternative therapies: A descriptive study

Development of a pharmacy practice intervention: lessons from the literature

What is polypharmacy? A systematic review of definitions

Contact Info

Product

Resources

About